Dr. Rich Sonnenblick

Dr. Rich Sonnenblick is the chief data scientist at Planview, joining the company in 2022 through the acquisition of Enrich, where he was CEO and founder. Rich’s experiences working with some of the largest pharmaceutical and medical device manufacturers in the world have enabled him to develop innovative, cloud-based solutions for high-impact, high-risk R&D decision-making. Including modules for prioritization and portfolio review processes, scenario planning, and integrated market, clinical, and financial valuation and forecasting methods, these solutions revolutionized the way drugs and devices are researched, developed, and launched. Rich oversees the development and implementation of both predictive and generative artificial intelligence features across the Planview platform of products.